Markets:

Overview

News

Currencies

International

Treasuries

Lisata Therapeutics, Inc. - Common Stock (NQ:LSTA)

3.595 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Lisata Therapeutics, Inc. - Common Stock

< Previous 1 2 Next >

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 09, 2026

Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's after-market session. The market value of their outstanding shares is at $143.1 million. Lisata Therapeutics...

Via Benzinga

In today's session, these stocks are experiencing unusual volume. ↗

January 27, 2026

Via Chartmill

The trading volume of these stocks is deviating from the norm in today's session. ↗

January 22, 2026

Via Chartmill

Lisata Shares Nearly Double On Buyout Offer: Here Are The Details ↗

January 21, 2026

Lisata said that it has entered into a binding term sheet under which the two companies agreed to negotiate in good faith and enter into a customary purchase agreement.

Via Stocktwits

Topics Workforce

Lisata Therapeutics (NASDAQ:LSTA) Reports Narrower-Than-Expected Q3 2025 Loss ↗

November 06, 2025

Lisata Therapeutics reported a narrower-than-expected Q3 2025 loss, advancing its lead candidate, certepetide, with a cash runway into 2027.

Via Chartmill

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Earnings Outlook For Lisata Therapeutics ↗

November 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 21, 2025

Via Benzinga

Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales ↗

January 22, 2025

Via Benzinga

Nasdaq Surges 1.5%; Procter & Gamble Posts Upbeat Earnings ↗

January 22, 2025

Via Benzinga

Recap: Lisata Therapeutics Q4 Earnings ↗

February 29, 2024

Via Benzinga

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

Lisata Therapeutics's Earnings Outlook ↗

February 28, 2024

Via Benzinga

Earnings Preview: Lisata Therapeutics ↗

November 01, 2023

Via Benzinga

US Stocks Higher; Netflix Profit Beats Estimates ↗

January 22, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 22, 2025

Via Benzinga

Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

January 22, 2025

Via Benzinga

LSTA Stock Earnings: Lisata Therapeutics Beats EPS for Q2 2024 ↗

August 12, 2024

LSTA stock results show that Lisata Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

EXCLUSIVE: Haystack Oncology Inks Research Collaboration With Lisata Therapeutics To Use Haystack MRD Technology To Evaluate Pancreatic Cancer Therapy Efficacy ↗

July 18, 2024

Haystack Oncology, a Quest Diagnostics company, and Lisata Therapeutics collaborate to use Haystack MRD technology in a study of certepetide plus chemotherapy for metastatic pancreatic cancer, focusing...

Via Benzinga

Lisata Therapeutics gets 2024 off to a strong start as it prepares for crucial ASCEND trial results

May 13, 2024

Lisata Therapeutics gets 2024 off to a strong start as it prepares for crucial ASCEND trial results

Via News Direct

LSTA Stock Earnings: Lisata Therapeutics Beats EPS for Q1 2024 ↗

May 09, 2024

LSTA stock results show that Lisata Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Earnings Scheduled For March 30, 2023 ↗

March 30, 2023

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.

Via Benzinga

Earnings Scheduled For August 14, 2023 ↗

August 14, 2023

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 23, 2022

OnFriday, 143 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

December 14, 2022

On Wednesday, 115 stocks hit new 52-week lows.

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.